Canaccord Genuity Raises Price Target for BioMarin Pharmaceutical Inc.
Canaccord Genuity has increased its price target for BioMarin Pharmaceutical Inc. from $114 to $117.
Stocks · News reference
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Canaccord Genuity has increased its price target for BioMarin Pharmaceutical Inc. from $114 to $117.
Wells Fargo analyst Ken Gawrelski has maintained a 'Buy' rating on Roblox Corporation while lowering the price target from $64 to $62.
GeoPark plans to invest $7 billion to develop the Bare oilfield in Venezuela, aiming to increase production to 90,000 barrels per day by 2038.
Science Applications International Corporation (SAIC) has announced it will release its third quarter fiscal year 2027 financial results before the market opens on December 3, 2026.
AMC Entertainment and Roblox have split the quarterly revenue lead evenly over the past two years, but their growth trajectories differ significantly. AMC shows cyclical, film-slate-driven revenue patterns with Q3 2026 reaching an all-time high of $1.7 billion, while Roblox demonstrates steady but decelerating growth, with year-over-year increases slowing from 48% in Q3 2025 to 16% in Q3 2026. The article suggests investors should monitor whether one company will establish a consistent lead going forward.
The Roblox experience 'TTK Testing' by Sable Digital has been named a nominee for the 'Best User Creation' category at The Game Awards 2026.